Cargando…
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates
We compare and contrast the expected duration and number of infections and deaths averted among several designs for clinical trials of COVID-19 vaccine candidates, including traditional and adaptive randomized clinical trials and human challenge trials. Using epidemiological models calibrated to the...
Autores principales: | Berry, Donald A., Berry, Scott, Hale, Peter, Isakov, Leah, Lo, Andrew W., Siah, Kien Wei, Wong, Chi Heem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757868/ https://www.ncbi.nlm.nih.gov/pubmed/33362278 http://dx.doi.org/10.1371/journal.pone.0244418 |
Ejemplares similares
-
Estimation of clinical trial success rates and related parameters
por: Wong, Chi Heem, et al.
Publicado: (2019) -
Corrigendum: Estimation of clinical trial success rates and related parameters
por: Wong, Chi Heem, et al.
Publicado: (2019) -
Multimorbidity and mortality: A data science perspective
por: Siah, Kien Wei, et al.
Publicado: (2022) -
Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?
por: Ben Chaouch, Zied, et al.
Publicado: (2022) -
The reaction of sponsor stock prices to clinical trial outcomes: An event study analysis
por: Singh, Manish, et al.
Publicado: (2022)